Saudi Journal of Ophthalmology
Volume 25, Issue 2 , Pages 159-167 , April 2011

Orbital retinoblastoma: Present status and future challenges – A review

Received 24 September 2010 ,Accepted 6 October 2010.

References 

  1. Abramson DH, Niksarli K, Ellsworth RM, et al. Changing trends in the management of retinoblastoma 1951–1965 vs 1966–1980. J. Pediatr. Ophthalmol. Strabismus. 1994;31:32–37
  2. Abramson DH, Beaverson K, Sangani P, et al. Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival. Paediatrics. 2003;112:1248–1255
  3. Acquaviva A, Barberi L, Bernardini C, et al. Medical therapy of retinoblastoma in children. J. Neurosurg. Sci. 1982;26:49–52
  4. Ajaiyeoba IA, Akang EE, Campbell OB, et al. Retinoblastomas in Ibadan: treatment and prognosis. West Africa J. Med. 1993;12:223–227
  5. Ali, M.J., Gupta, R., Vemuganti, G.K., Honavar, S.G., 2009. Histopathology of retinoblastoma after primary chemotherapy. In: Proceedings of the XIV International Congress of Ocular Oncology, Cambridge, p. 296.
  6. Ali MJ, Parsam VL, Honavar SG, et al. RB1 gene mutations in retinoblastoma and its clinical correlation. Saudi J. Ophthalmol. 2010;24:119–123
  7. Amendola BE, Lamm RF, Markoe AM, et al. Radiotherapy of retinoblastoma. A review of 63 children treated with different irradiation techniques. Cancer. 1990;66:21–26
  8. Anonymous, 1992. Survival rate and risk factors for patients with retinoblastoma in Japan. The committee for the National Registry of Retinoblastoma. Jpn. J. Ophthalmol., 36, 121–131.
  9. Antoneli CB, Steinhorst F, de Cassia Braga RK, et al. Extra ocular retinoblastoma a 13-year experience. Cancer. 2003;98:1292–1298
  10. Badhu B, Sah SP, Thakur SK, et al. Clinical presentation of retinoblastoma in Eastern Nepal. Clin. Exp. Ophthalmol. 2005;33:386–389
  11. Bakhshi S, Meel R, Mohanti BK, et al. Treatment and outcomes of non-metastatic extra-ocular retinoblastoma with uniform chemotherapy protocol. J. Pediatr. Hematol. Oncol. 2010;32:42–45
  12. Bishop JO, Madsen EC. Retinoblastoma review of current status. Surv. Ophthalmol. 1975;19:342–366
  13. Chantada G, Fadino A, Manzitti J, et al. Late diagnosis of retinoblastomas in a developing country. Arch. Dis. Child. 1999;80:171–174
  14. Chantada G, Fadino A, Casak S, et al. Treatment of overt extra-ocular retinoblastoma. Med. Pediatr. Oncol. 2003;40:158–161
  15. Doz F, Khelfaoui F, Mosseri V, et al. The role of chemotherapy in orbital involvement of retinoblastoma. The experience of single institution with 33 patients. Cancer. 1994;74:722–732
  16. Doz F, Neuenschwaner S, Plantaz D, et al. Etoposide and carboplatin in retinoblastomas a study by the Societe Francaise d’Oncologie Pediatrique. J. Clin. Oncol. 1995;13:902–909
  17. Ellsworth RM. Orbital Retinoblastoma. Trans. Am. Ophthalmol. Soc. 1974;72:79–88
  18. Finger PT, Harbour JW, Karcioglu ZA. Risk factors for metastasis in retinoblastoma. Surv. Ophthalmol. 2002;47:1–16
  19. Goble RR, Mckenzie J, Kingston JE, et al. Orbital recurrence of retinoblastoma successfully treated by combined therapy. Br. J. Ophthalmol. 1990;74:97–98
  20. Grabowski EF, Abramson DH. Intraocular and extra ocular retinoblastoma. Hematol. Oncol. Clin. North. Am. 1987;1:721–735
  21. Honavar, S.G., 2007. Orbital Retinoblastoma. In: Singh, A.D., Damato, B.E., Pe’er, J., et al. (Eds.), Clinical Ophthalmic Oncology, first ed., Saunders Elsevier, pp. 477–483.
  22. Honavar SG, Singh AD. Management of advanced retinoblastoma. Ophthalmol. Clin. North. Am. 2005;18:65–73
  23. Honavar G, Singh A, Shields C, et al. Post enucleation adjuvant therapy in high risk retinoblastoma. Arch. Ophthalmol. 2002;120:923–931
  24. Hungerford J. Factors influencing metastasis in retinoblastoma. Br. J. Ophtalmol. 1993;77:541
  25. Hungerford JL, Kingston JE, Plowman PN. Orbital recurrence of retinoblastoma. Ophthalmic. Pediatr. Genet. 1987;8:63–68
  26. Kao LY, Su WW, Lin YW. Retinoblastoma in Taiwan: survival and clinical characteristics 1978–2000. Jpn. J. Ophthalmol. 2002;46:577–580
  27. Kauffman EC, Robinson VL, Stadler WM, et al. Metastasis Suppression: the Evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J. Urol. 2003;169:1122–1133
  28. Khelfaoui F, Validire P, Auperin A, et al. Histopathologic risk factors in retinoblastoma a retrospective study of 172 patients treated in a single institution. Cancer. 1996;77:1206–1213
  29. Kiratli PO, Kiratli H, Ercan MT. Visualization of orbital retinoblastoma with technetium-99m (V) dimercaptosuccinic acid. Ann. Nucl. Med. 1998;12:157–159
  30. Kodilinye HC. Retinoblastoma in Nigeria: problems of treatment. Am. J. Ophthalmol. 1967;63:469–481
  31. Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 1987;94:371–377
  32. Kremens B, Wieland R, Rienhart H, et al. High dose chemotherapy with autologous stem cell in children with retinoblastoma. Bone Marrow Transplant. 2003;31:281–284
  33. Leal-Leal C, Flores-Rojo M, Medina-Sanson A, et al. A multi-centre report from the Mexican retinoblastoma group. Br. J. Ophthalmol. 2004;88:1074–1077
  34. Leander C, Fu LC, Pena A. Impact of an education programme on the late diagnosis of retinoblastoma in Honduras. Pediatr. Blood Cancer. 2007;49:817–819
  35. Lee SH, Yoo KH, Sung KW, et al. Tandem high-dose chemotherapy and autologous stem cell rescue in children with bilateral advanced retinoblastoma. Bone Marrow Transplant. 2008;42:385–391
  36. Maat-Kevit JA, Oepkes D, Hartwing NG, et al. A large retinoblastoma detected in a fetus at 21 weeks of gestation. Prenat. Diagn. 1993;13:377–384
  37. Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology. 1989;96:217–222
  38. Menon BS, Reddy SC, Wan Maziah WN, et al. Extra ocular retinoblastoma. Med. Pediatr. Oncol. 2000;35:75–76
  39. Messmer EP, Heinrich T, Hopping W, et al. Risk factors for metastases in patients with retinoblastoma. Ophthalmology. 1989;96:217–222
  40. Moll AC, Hoekstra OS, Imhof SM, et al. Flourine-18 flourodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience. Ophthalm. Genet. 2004;25:31–35
  41. Munier FL, Verwey J, Pica A, et al. New developments in external beam radiotherapy in retinoblastoma From lens to normal tissue-sparing techniques. Clin. Exp. Ophthalmol. 2008;36:78–89
  42. Parsam VL, Kannabiran C, Honavar SG, et al. A compréhensive, sensitive and economical approach for the detection of mutations in RB1 gene in retinoblastoma. J. Genet. 2009;88:517–527
  43. Reese, A.B., 1963. Tumors of the eye. Harper and Row, New York, pp. 155–156.
  44. Rootman J, Ellsworth RM, Hofbauer J, et al. Orbital extension of retinoblastoma a clinicopathological study. Can. J. Ophthalmol. 1978;13:72–80
  45. Salim A, Wiknjosastro GH, Danukusumo D, et al. Fetal retinoblastoma. L. Ultrasound Med. 1998;17:717–720
  46. Sanders BM, Draper GJ, Kingston JE. Retinoblastoma in Great Britain 1969–1980: incidence, treatment and survival. Br. J. Ophthalmol. 1988;72:56–583
  47. Schvartzman E, Chantada G, Fandino A, et al. Results of a stage-based approach for the treatment of retinoblastoma. J. Clin. Oncol. 1996;14:1532–1536
  48. Scott IU, Murray TG, Feuer WJ, et al. External beam radiotherapy in retinoblastoma tumor control and comparison of two techniques. Arch. Ophthalmol. 1999;117:766–770
  49. Shields, J.A., Shields, C.L., 1992. Intraocular tumors – A text and Atlas. WB Saunders, Philadelphia, PA, USA.
  50. Shields CL, Shields JA. Retinoblastoma management: Advances in enucleation, intravenous chemoreduction and intra-arterial chemotherapy. Curr. Opin. Ophthalmol. 2010;21:203–212
  51. Shields CL, Shields JA, Baez KA, et al. Optic nerve invasion of retinoblastoma metastatic potential and clinical risk factors. Cancer. 1994;73:692–698
  52. Shields CL, Honavar SG, Shields JA, et al. Vitrectomy in eyes with unsuspected retinoblastoma. Ophthalmology. 2000;107:2250–2255
  53. Singh AD, Shields CL, Shields JA. Prognostic factors in retinoblastoma. J. Pediatr. Ophthalmol. Strabismus. 2000;37:134–141
  54. Stannard C, Lipper S, Sealy R, et al. Retinoblastoma: correlation of invasion of the optic nerve and choroids with prognosis and metastases. Br. J. Ophthalmol. 1979;63:560–570
  55. Uusitalo M, Van Quill K, Scott I, et al. Evaluation of chemoprophylaxis inpatients with unilateral retinoblastoma with high risk features on histopathological examination. Arch. Ophthalmol. 2001;119:41–48
  56. Vemuganti GK, Honavar SG, John R. Clinicopathological profile of retinoblastoma in Asian Indians. Invest. Ophthalmol. Vis. Sci. 2000;41:790;(S)
  57. White L. Chemotherapy in retinoblastoma: current status and future directions. Am. J. Pediatr. Hematol. Oncol. 1991;13:189–201
  58. Wilimas JA, Wilson MW, Haik BG, et al. Development of retinoblastoma programs in Central America. Pediatr. Blood Cancer. 2009;53:42–46
  59. Wolff, J.A., Boesel, C., Ellsworth, R.M. et al., 1978. Childrens Cancer Study Group – Protocol CCSG 962. Childrens Cancer Group, New York.
  60. Young, J., Smith, M.A., Roffers, S.D. et al., 1999. Retinoblastoma. In: Ries, L.A., Smith, M.A., Gurney, J.G. et al. (Eds.), Cancer incidence and survival among children and adolescents United States SEER Program. NIH Pub. No. 99-4649.

PII: S1319-4534(10)00108-6

doi: 10.1016/j.sjopt.2010.10.010

Saudi Journal of Ophthalmology
Volume 25, Issue 2 , Pages 159-167 , April 2011

Article Tools

* Image Usage & Resolution